Ear Wax Relief (Similasan Corporation)
Welcome to the PulseAid listing for the Ear Wax Relief drug offered from Similasan Corporation. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Similasan Corporation |
NON-PROPRIETARY NAME: | causticum, graphite, lachesis muta venom and lycopodium clavatum spore |
SUBSTANCE NAME: | CAUSTICUM; GRAPHITE; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | AURICULAR (OTIC) |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
START MARKETING DATE: | 2003-06-01 |
END MARKETING DATE: | 0000-00-00 |
Ear Wax Relief HUMAN OTC DRUG Details:
Item Description | Ear Wax Relief from Similasan Corporation |
LABELER NAME: | Similasan Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 12; 15; 12; 12([hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL) |
START MARKETING DATE: | 2003-06-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 59262-272_695616d1-adfe-407e-9e36-713040ce0928 |
PRODUCT NDC: | 59262-272 |
APPLICATION NUMBER: | |
Other CAUSTICUM; GRAPHITE; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE Pharmaceutical Manufacturers / Labelers: